These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 30326864)

  • 21. Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.
    Reggiani Bonetti L; Lionti S; Vitarelli E; Barresi V
    Virchows Arch; 2017 Dec; 471(6):731-741. PubMed ID: 28819729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
    Bruun J; Sveen A; Barros R; Eide PW; Eilertsen I; Kolberg M; Pellinen T; David L; Svindland A; Kallioniemi O; Guren MG; Nesbakken A; Almeida R; Lothe RA
    Mol Oncol; 2018 Sep; 12(9):1639-1655. PubMed ID: 29900672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.
    Osumi H; Shinozaki E; Suenaga M; Matsusaka S; Konishi T; Akiyoshi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Mise Y; Ishizawa T; Inoue Y; Takahashi Y; Saiura A; Uehara H; Mun M; Okumura S; Mizunuma N; Miki Y; Yamaguchi T
    Int J Cancer; 2016 Aug; 139(4):803-11. PubMed ID: 27004837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
    Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
    Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung Metastasectomy from Colorectal Cancer, 10-year Experience in a South American Cancer Center.
    Carvajal C; Facundo H; Puerto P; Carreño J; Beltrán R
    Front Surg; 2022; 9():913678. PubMed ID: 36034370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term Survival of Patients with Lung Metastases from Colorectal and Non-colorectal Cancer Who Underwent Pulmonary Metastasectomy.
    Lumachi F; Mazza F; Del Conte A; Lo Re G; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2015 Jun; 35(6):3563-6. PubMed ID: 26026126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peri-operative chemotherapy for resectable colorectal lung metastasis: a systematic review and meta-analysis.
    Li Y; Qin Y
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):545-553. PubMed ID: 32036456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients.
    Ribeirinho-Soares S; Pádua D; Amaral AL; Valentini E; Azevedo D; Marques C; Barros R; Macedo F; Mesquita P; Almeida R
    BMC Cancer; 2021 Apr; 21(1):359. PubMed ID: 33823840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter Study.
    Hishida T; Tsuboi M; Okumura T; Boku N; Ohde Y; Sakao Y; Yoshiya K; Hyodo I; Mori K; Kondo H
    Ann Thorac Surg; 2017 Feb; 103(2):399-405. PubMed ID: 27793399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
    Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
    Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forty-Two Years' Experience with Pulmonary Resections of Metastases from Colorectal Cancer.
    Dudek W; Schreiner W; Hohenberger W; Klein P; Sirbu H
    Thorac Cardiovasc Surg; 2017 Oct; 65(7):560-566. PubMed ID: 26962969
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
    Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor.
    Zabaleta J; Aguinagalde B; Fuentes MG; Bazterargui N; Izquierdo JM; Hernández CJ; Enriquez-Navascués JM; Emparanza JI
    Eur J Surg Oncol; 2011 Sep; 37(9):786-90. PubMed ID: 21723689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore.
    Baldin P; Van den Eynde M; Mlecnik B; Bindea G; Beniuga G; Carrasco J; Haicheur N; Marliot F; Lafontaine L; Fredriksen T; Lanthier N; Hubert C; Navez B; Huyghe N; Pagès F; Jouret-Mourin A; Galon J; Komuta M
    J Pathol Clin Res; 2021 Jan; 7(1):27-41. PubMed ID: 32902189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of patients with recurrence after pulmonary metastasectomy for colorectal cancer.
    Sakamaki Y; Ishida D; Tanaka R
    Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1172-1178. PubMed ID: 32323124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.